Standard BioTools Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $22.1M | $30.0M |
| Jun 2022 | — | $-37.5M | $74.4M |
| Sep 2022 | — | $-62.7M | $60.2M |
| Dec 2022 | $64.9M | $-81.5M | $81.3M |
| Mar 2023 | — | $-97.2M | $113.7M |
| Jun 2023 | $65.2M | $-113.4M | $142.3M |
| Sep 2023 | $64.6M | $-131.7M | $79.7M |
| Dec 2023 | $63.5M | $-148.1M | $51.7M |
| Mar 2024 | $55.0M | $577.3M | $287.1M |
| Jun 2024 | $55.1M | $510.3M | $269.8M |
| Sep 2024 | $55.2M | $489.3M | $210.6M |
| Dec 2024 | $299.0K | $471.7M | $166.7M |
| Mar 2025 | — | $454.6M | $150.9M |
| Jun 2025 | — | $424.5M | $158.6M |
| Sep 2025 | — | $399.7M | $129.4M |
| Dec 2025 | — | $424.3M | $120.9M |
| Mar 2026 | — | $561.1M | $265.8M |
| Jun 2026 | — | $540.0M | $270.0M |